HIV-I

Clinical trials for HIV-I explained in plain language.

Never miss a new study

Get alerted when new HIV-I trials appear

Sign up with your email to follow new studies for HIV-I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Monthly pill trial aims to stop HIV before it starts

Prevention Terminated

This study aimed to see if a new monthly oral pill (islatravir) could prevent HIV infection in women at high risk. It compared the monthly pill to a standard daily medication (FTC/TDF). The trial was stopped early for safety monitoring after lab tests showed potential effects on …

Matched conditions: HIV-I

Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention

Last updated Apr 01, 2026 14:41 UTC

HIV-I

Get alerted when new HIV-I trials appear

Monthly pill trial aims to stop HIV before it starts